A Viral Model for Corneal Scarring and Neovascularization Following Ocular Infection of Rabbits With a Herpes Simplex Virus Type 1 (HSV-1) Mutant
- 1 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Cornea
- Vol. 24 (4) , 460-466
- https://doi.org/10.1097/01.ico.0000138833.34865.39
Abstract
Herpes simplex virus type 1 (HSV-1) remains a major cause of corneal scarring and visual loss. Although efforts have been made, no reproducible animal model is available to examine recurrent corneal disease. Here we propose a rabbit ocular model to study recurrent corneal disease using an HSV-1 mutant that reactivates with high efficiency. Rabbits were ocularly infected with 2 × 105 PFU/eye of the parental McKrae, dLAT2903 (a LAT-null virus with a low-reactivation phenotype), or CJLAT (a high-reactivation virus). Acute ocular disease [days 2, 4, 7, and 10 postinfection (pi)], recurrent ocular disease, and neovascularization (days 30 to 58 pi) were monitored. All acute ocular disease symptoms, including conjunctivitis and corneal disease, were similar with all 3 viruses. No corneal scarring was detected in any eyes up to day 30 pi. Between days 35 and 58 pi, corneal scarring was observed in 11/14 (experiment 1) and 18/22 (experiment 2) eyes of CJLAT-infected rabbits. Significantly less corneal scarring was seen in eyes of rabbits infected with McKrae (0/18 and 0/16) or dLAT2903 (0/16 and 3/24) (P < 0.0001). Many of the eyes with corneal scarring developed obvious, measurable neovascularization. Rabbits infected with CJLAT developed corneal scarring and neovascularization similar to that of clinical ocular HSV-1 recurrent disease. Because this occurred well after the acute infection had resolved, the corneal scarring and neovascularization appeared to be recurrent disease. Thus, CJLAT ocular infection of rabbits may provide a good and reproducible animal model to study factors involved in corneal scarring and neovascularization from recurrent ocular HSV-1.Keywords
This publication has 60 references indexed in Scilit:
- Gene therapy for ocular angiogenesisClinical Science, 2003
- Identification of Herpes Simplex Virus Type 1 Latency-Associated Transcript Sequences That both Inhibit Apoptosis and Enhance the Spontaneous Reactivation PhenotypeJournal of Virology, 2003
- Three Herpes Simplex Virus Type 1 Latency-Associated Transcript Mutants with Distinct and Asymmetric Effects on Virulence in Mice Compared with RabbitsJournal of Virology, 2001
- Immunologic Approach to Herpes Simplex VirusViral Immunology, 2001
- Virus-Induced Neuronal Apoptosis Blocked by the Herpes Simplex Virus Latency-Associated TranscriptScience, 2000
- Herpes Simplex Virus Replication-Induced Expression of Chemokines and Proinflammatory Cytokines in the Eye: Implications in Herpetic Stromal KeratitisJournal of Interferon & Cytokine Research, 1998
- Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits.British Journal of Ophthalmology, 1991
- RNA Complementary to a Herpesvirus α Gene mRNA Is Prominent in Latently Infected NeuronsScience, 1987
- Pathogenesis and InhibitionCornea, 1987
- An animal model for the assessment of microvascular patencyHead & Neck Surgery, 1983